These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 30888584

  • 21. Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients.
    Ulutas O, Taskapan H, Taskapan MC, Temel I.
    Int Urol Nephrol; 2013 Jun; 45(3):879-84. PubMed ID: 23065434
    [Abstract] [Full Text] [Related]

  • 22. Effect of vitamin D supplementation on selected inflammatory biomarkers in older adults: a secondary analysis of data from a randomised, placebo-controlled trial.
    Waterhouse M, Tran B, Ebeling PR, English DR, Lucas RM, Venn AJ, Webb PM, Whiteman DC, Neale RE.
    Br J Nutr; 2015 Sep 14; 114(5):693-9. PubMed ID: 26206095
    [Abstract] [Full Text] [Related]

  • 23. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.
    Molina P, Górriz JL, Molina MD, Peris A, Beltrán S, Kanter J, Escudero V, Romero R, Pallardó LM.
    Nephrol Dial Transplant; 2014 Jan 14; 29(1):97-109. PubMed ID: 23975842
    [Abstract] [Full Text] [Related]

  • 24. Vitamin D supplementation improves endothelial dysfunction in patients with non-dialysis chronic kidney disease.
    Zhang Q, Zhang M, Wang H, Sun C, Feng Y, Zhu W, Cao D, Shao Q, Li N, Xia Y, Tang T, Wan C, Liu J, Jin B, Zhao M, Jiang C.
    Int Urol Nephrol; 2018 May 14; 50(5):923-927. PubMed ID: 29484540
    [Abstract] [Full Text] [Related]

  • 25. A randomized double-blind placebo-controlled trial of vitamin D supplementation in juvenile-onset systemic lupus erythematosus: positive effect on trabecular microarchitecture using HR-pQCT.
    Lima GL, Paupitz JA, Aikawa NE, Alvarenga JC, Pereira RMR.
    Osteoporos Int; 2018 Mar 14; 29(3):587-594. PubMed ID: 29152675
    [Abstract] [Full Text] [Related]

  • 26. Cholecalciferol Supplementation Did Not Change Interleukin-7 and B cell-Activating Factor Levels and CD95 Expression in B lymphocytes in Patients on Dialysis: A Randomized Pilot-Controlled Trial.
    de Carvalho JTG, Schneider M, Cuppari L, Grabulosa CC, Cendoroglo M, Dalboni MA.
    J Ren Nutr; 2019 Sep 14; 29(5):454-461. PubMed ID: 30686751
    [Abstract] [Full Text] [Related]

  • 27. Effect of vitamin D supplementation on serum sclerostin levels in chronic kidney disease.
    Yadav AK, Kumar V, Banerjee D, Gupta KL, Jha V.
    J Steroid Biochem Mol Biol; 2018 Jun 14; 180():15-18. PubMed ID: 29331722
    [Abstract] [Full Text] [Related]

  • 28. Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D.
    Marckmann P, Agerskov H, Thineshkumar S, Bladbjerg EM, Sidelmann JJ, Jespersen J, Nybo M, Rasmussen LM, Hansen D, Scholze A.
    Nephrol Dial Transplant; 2012 Sep 14; 27(9):3523-31. PubMed ID: 22822092
    [Abstract] [Full Text] [Related]

  • 29. The effect of a single, large bolus of vitamin D in healthy adults over the winter and following year: a randomized, double-blind, placebo-controlled trial.
    Kearns MD, Binongo JN, Watson D, Alvarez JA, Lodin D, Ziegler TR, Tangpricha V.
    Eur J Clin Nutr; 2015 Feb 14; 69(2):193-7. PubMed ID: 25271011
    [Abstract] [Full Text] [Related]

  • 30. VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.
    Courbebaisse M, Alberti C, Colas S, Prié D, Souberbielle JC, Treluyer JM, Thervet E.
    Trials; 2014 Nov 06; 15():430. PubMed ID: 25376735
    [Abstract] [Full Text] [Related]

  • 31. Oral vitamin D3 supplementation increases serum fibroblast growth factor 23 concentration in vitamin D-deficient patients: a systematic review and meta-analysis.
    Charoenngam N, Rujirachun P, Holick MF, Ungprasert P.
    Osteoporos Int; 2019 Nov 06; 30(11):2183-2193. PubMed ID: 31372708
    [Abstract] [Full Text] [Related]

  • 32. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study.
    Delanaye P, Weekers L, Warling X, Moonen M, Smelten N, Médart L, Krzesinski JM, Cavalier E.
    Nephrol Dial Transplant; 2013 Jul 06; 28(7):1779-86. PubMed ID: 23378417
    [Abstract] [Full Text] [Related]

  • 33. Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.
    Kendrick J, Andrews E, You Z, Moreau K, Nowak KL, Farmer-Bailey H, Seals DR, Chonchol M.
    Clin J Am Soc Nephrol; 2017 Sep 07; 12(9):1438-1446. PubMed ID: 28784657
    [Abstract] [Full Text] [Related]

  • 34. Pilot study of the effect of cholecalciferol supplementation on hepcidin in children with chronic kidney disease: Results of the D-fense Trial.
    Atkinson MA, Juraschek SP, Bertenthal MS, Detrick B, Furth SL, Miller ER.
    Pediatr Nephrol; 2017 May 07; 32(5):859-868. PubMed ID: 28013381
    [Abstract] [Full Text] [Related]

  • 35. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
    Strugnell SA, Sprague SM, Ashfaq A, Petkovich M, Bishop CW.
    Am J Nephrol; 2019 May 07; 49(4):284-293. PubMed ID: 30878999
    [Abstract] [Full Text] [Related]

  • 36. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
    Ardabili HR, Gargari BP, Farzadi L.
    Nutr Res; 2012 Mar 07; 32(3):195-201. PubMed ID: 22464806
    [Abstract] [Full Text] [Related]

  • 37. A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease.
    Moe SM, Saifullah A, LaClair RE, Usman SA, Yu Z.
    Clin J Am Soc Nephrol; 2010 Feb 07; 5(2):299-306. PubMed ID: 20056760
    [Abstract] [Full Text] [Related]

  • 38. Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial.
    Dalbeni A, Scaturro G, Degan M, Minuz P, Delva P.
    Nutr Metab Cardiovasc Dis; 2014 Aug 07; 24(8):861-8. PubMed ID: 24787908
    [Abstract] [Full Text] [Related]

  • 39. Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial.
    Massart A, Debelle FD, Racapé J, Gervy C, Husson C, Dhaene M, Wissing KM, Nortier JL.
    Am J Kidney Dis; 2014 Nov 07; 64(5):696-705. PubMed ID: 24856872
    [Abstract] [Full Text] [Related]

  • 40. Impact of Bioelectrical Impedance-Guided Fluid Management and Vitamin D Supplementation on Left Ventricular Mass in Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial.
    Brimble KS, Ganame J, Margetts P, Jain A, Perl J, Walsh M, Bosch J, Yusuf S, Beshay S, Su W, Zimmerman D, Lee SF, Gangji AS.
    Am J Kidney Dis; 2022 Jun 07; 79(6):820-831. PubMed ID: 34656640
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.